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Aims.T oe x p l o r et h ee ﬀects of the high expression of MMP9 on biological behaviors of ﬁbroblasts. Methods. High glucose and
hyperhomocysteine were used to induce MMP9 expression in skin ﬁbroblasts. Cell proliferation was detected by ﬂow cytometry
and cell viability by CCK-8. ELISA assay was used to detect collagen (hydroxyproline) secretion. Scratch test was employed to
evaluate horizontal migration of cells and transwell method to evaluate vertical migration of cells. Results. The mRNA and protein
expressions of MMP9 and its protease activity were signiﬁcantly higher in cells treated with high glucose and hyperhomocysteine
than those in control group. At the same time, the S-phase cell ratio, proliferation index, cell viability, collagen (hydroxyproline)
secretion,horizontalmigrationrate,andthenumberofvertical migrationcellsdecreasedinhigh-glucoseandhyperhomocysteine-
treated group. Tissue inhibitor of metalloproteinase 1 (TIMP1), which inhibits the activity of MMP9, recovered the above bio-
logicalbehaviors.Conclusions.HighexpressionofMMP9inskinﬁbroblastscouldbeinducedbycultureinginhighglucoseandhy-
perhomocysteine medium, which inhibited cell biological behaviors. Inhibitions could be reversed by TIMP1. The ﬁndings sug-
gested that MMP9 deters the healing of diabetic foot ulcers by inhibiting the biological behaviors of ﬁbroblasts.
1.Introduction
It is well known that ulcers of diabetic foot are refractory
and can cause considerable morbidity and mortality [1]. In
recent years, domestic and international studies have found
thatincreasedmatrixmetalloproteinases(MMPs)expression
would contribute to the vulnerability of diabetic skin and the
refractory nature of diabetic foot ulcers, especially MMP9
[2, 3]. MMPs are proteinases that participate in extracellular
matrix macromolecule degradation. MMP9 is one of this
growing family. An important mechanism for the regulation
of the activity of MMPs is via binding to members of the
family of proteins referred to as tissue inhibitor of met-
alloproteinases (TIMPs). Our previous studies have shown
that local abnormal expression of MMP9 in the skin was
correlated with skin damage. As compared with nondiabetic
rats,theprocessofwoundhealingintheskinsloweddownin
diabetic rat and, at the same time, levels of MMP9 increased
signiﬁcantly, while TIMP1, the tissue-speciﬁc inhibitor of
MMP9, decreased in the diabetic group [4–6].
It is widely recognized that high levels of MMP9 slow
downthehealingofdiabeticfootulcersbyexcessivedegrada-
tion of extracellular matrix, growth factors, growth factor
receptors, integrins, and their receptors, as well as increasing
the local inﬂammatory response in the wound [7–9]. It is
still unknown whether MMP9 can inﬂuence the biologi-
cal behaviors of skin ﬁbroblasts and aﬀect wound healing.
Skin ﬁbroblasts play important roles in wound repairing.
Anything that can aﬀect their biological properties will ulti-
mately aﬀect wound healing. To investigate the mechanisms
of MMP9 in diabetic foot wound healing, rat skin ﬁbroblasts
were cultured in high glucose and hyperhomocysteine med-
ium [10–12]. Changes of biological behaviors of skin ﬁbrob-
lasts were observed before and after using the exogenous
TIMP1.2 Experimental Diabetes Research
2. Methods
2.1. Cell Culture and Grouping. Fibroblasts (CRL-1213,
ATCC,USA)wereculturedinDMEM(Gibco,USA)contain-
ing 10% fetal bovine serum (FBS, Hyclone, USA) in a CO2
incubator (37◦C, 5% CO2). After 24-hour serum deprivation
(0.5% FBS), ﬁbroblasts were cultured in DMEM containing
10% FBS at three diﬀerent conditions (according to the
grouping) for 6 hours in a CO2 incubator (37◦C, 5% CO2).
Grouping: (1) Control group was cultured in DMEM
containing normal glucose (5.5mmol/L). (2) Model group
was cultured in DMEM containing glucose (22.0mmol/L)
and homocysteine (100μmol/L) [10–12]. (3) TIMP1 group
was cultured in DMEM containing glucose (22.0mmol/L),
homocysteine (100μmol/L), and TIMP1 (100μg/L, R and D
Systems, Minneapolis, USA).
2.2. Determination of MMP9 Levels. MMP9 mRNA expres-
sion was determined by real-time polymerase chain reaction
(real-time-PCR) [13]. Total RNA was extracted by Trizol
(Invitrogen, Carlsbad, CA, USA) from cells. To quantify
MMP9 mRNA levels by real-time-PCR, GAPDH was used
as the internal control. Primers were designed by Invit-
rogen Corporation (Carlsbad, CA, USA) according to the
sequences of rat MMP9 and GAPDH in GeneBank. Rat
MMP9primersweresense,5 -TCCAGTAGACAATCCTTG-
CAATGTG-3 ; anti-sense, 5 -CTCCGTGATTCGAGAACT-
TCCAATA-3 . Rat GAPDH primers were sense, 5 -GGC-
ACAGTCAAGGCTGAGAATG-3 ; anti-sense, 5 -ATGGTG-
GTGAAGACGCCAGTA-3 . Ampliﬁcation was performed
according to the instructions of the SYBR PrimeScript
PCR Kit (Takara, Kyoto, Japan). Brieﬂy, SYBR Premix Ex
TaqTM (2×)1 0 μL, PCR Forward Primer (10μM) 0.4μL,
PCR Reverse Primer (10μM) 0.4μL, ROX Reference Dye
(50×)0 . 4 μL, and cDNA template 2.0μL were added into
a microfuge tube along with distilled water to make a
total volume of 20.0μL .T h eP C Rr e a c t i o n sw e r ep e r f o r m e d
in a LightCycler 480 real-time-PCR system (Roche, Basel,
Switzerland), with denaturation at 95◦C for 30sec, then 40
cycles of 95◦C for 5sec followed by elongation at 60◦Cf o r
20sec. In order to ensure equal sample sizes, the real-time-
PCR for GADPH was performed at the same time. Melting
curve analysis was conducted to ensure the speciﬁcity of
ampliﬁcation, the products were quantitated by the 2−ΔΔCT
method, and the diﬀerence between the Ct values of MMP9
and the corresponding value of GADPH in each sample was
used as the relative MMP9 Ct value.
MMP9 protein was measured by ELISA assay. At the
end of cells culture, supernatants were collected. Double-
antibody sandwich ABC-ELISA was used to detect protein
expression of MMP9. Operation was performed according
to the instructions of the rat MMP9 ELISA kit (Uscn Life
Science Inc., Wuhan, China).
MMP9 protease activity in cell culture supernatants were
assessed by gelatin zymography [14] .E q u a la l i q u o t so fc o n -
ditioned culture media from an equal number of cells were
fractionated using precast zymogram gels containing gelatin,
accordingtothemanufacturerprotocol(GuangDongChem-
icalreagent Inc., Guangzhou, China). After electrophoresis,
gels were incubated in renaturing buﬀer (50mmol/L Tris-
HCl (pH 7.4), 2% (vol/vol) Triton X-100) for 30min at
room temperature and then incubated in developing buﬀer
(50mmol/L Tris-HCl (pH 8.0), 2.5mmol/L CaCl2, 0.02%
(wt/vol) Brij-35) for 72h at 37◦C. Lytic bands correspond-
ing to the latent form of MMP9 (92kDa) were analyzed as
total activity and visualized by staining with 0.5% (wt/vol)
Coomassie Brilliant Blue solution. The gels were photo-
graphed, followed by analysis using Image Quant 5.2 soft-
ware.
2.3. Proliferation of Cells. Proliferation of cells was assessed
by ﬂow cytometry [15]. Cells were collected into the de-
dicated tube for ﬂow cytometry and centrifuged for 6min
(2500r/min), and supernatant was discarded. Cells were
resuspended with 1mL PBS. Then 300μL of cell suspension
was added into 700μL ice-cold ethanol drop by drop, ﬁxed
overnight at 4◦C in the dark. On the next day, suspension
was centrifuged for 10min (2500r/min) and supernatant
was discarded. Cells were resuspended again with 500μLPBS
containing RNase A (100U/mL), incubated for 30min at
37◦C. Then ethidium bromide (2mg/mL) was added to a
ﬁnal concentration of 50μg/mL and incubated for 30min in
the dark. Cells cycle was detected by standard procedures of
ﬂow cytometry, and the S-phase cell ratio and proliferation
index were calculated at the same time. S-phase cell ratio is
S/(G0/G1 + S + G2/M); proliferation index is (S + G2/M)/
( G 0 / G 1+S+G 2 / M ) .
2.4. Viability of Cells. Viability of cells was assessed by CCK-
8 (Dojindo Laboratories, Kumamoto, Japan) [16]. Cells were
inoculated to 96-well plates according to the density of 2.0-
3.0 × 103 cells for each well. Premixed CCK-8 and medium
(10μL:100μL)wereaddedinto96-wellplates,andcellswere
then incubated for 0.5–1h at 37◦C .T h ev a l u e so fA 4 5 0w e r e
obtained with the 3,550 automatic detector from Beckman
(Brea, CA).
2.5. Collagen (Hydroxyproline) Secretion. Collagen (hydrox-
yproline) secretion was detected by ELISA. Hydroxyproline
was measured according to the instructions of the rat hydro-
xyproline ELISA kit (Xinqidi Biological Technology Co.,
Wuhan, China). The concentration of hydroxyproline was
calculated according to the A450 value obtained with the
3,550 automatic detector from Beckman (Brea, CA).
2.6. Horizontal Migration of Cells. Horizontal migration was
assessed by scratch test [17]. Cells cultured in 6-well plates
were scratched with a small tip along the ruler. Washing the
scratch area was repeated with PBS until the cells in this
area were removed thoroughly. Adding the purpose med-
ium and culturing 6h, we chose ﬁve diﬀerent horizons under
the inverted microscope and measured the distance between
cells at 0h and 6h after scratching, taking the average
for horizontal migration rate. Horizontal migration rate is
(width at 0h − width at 6h)/width at 0h × 100%.
2.7. Vertical Migration of Cells. Transwell was used to
evaluate the vertical migration of cells [18]. Cells in theExperimental Diabetes Research 3
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Figure 1: Establishment of the ﬁbroblasts cell model of high matrix metalloproteinase 9 (MMP9) expression. The expressions of MMP9
mRNA, protein levels, and protease activity in model group were 6.05-, 4.12-, and 1.62-fold, respectively, greater than those in control
group, which suggested that high expression of MMP9 was induced. When the cells were treated with tissue inhibitor of metalloproteinase 1
(TIMP1), the expression of MMP9 mRNA and protein had no statistical diﬀerences compared with model group. ∗P<0.01 versus control
group. Data are mean ± SEM, n = 5.
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Figure 2: Matrix metalloproteinase 9 (MMP9) activity detected by
Gelatin zymography. The activity of MMP9 in model group was
1.62-fold greater than that in control group. When the cells were
treated with tissue inhibitor of metalloproteinase 1 (TIMP1), the
activity of MMP9 decreased by 70.7% compared with model group.
∗P<0.01versuscontrolgroup; #P<0.01versusmodelgroup.Data
are mean ± SEM, n = 5.
logarithmic growth phase were suspended by purpose med-
ium containing 0.5% FBS after conventional digestion.
100μL cell suspensions (1.0 × 105/mL) were added into the
upper chamber, and 500μL purpose medium (according to
the grouping) containing 10% FBS was added into the low-
er chamber. After 16h of culture, the upper chamber was
removed, ﬁxed for 30min with 4% paraformaldehyde, and
stained for 15min with crystalline violet. We selected four
visions randomly to count the number of cells moved to the
lower of the membrane under inverted microscope, taking
the average for the number of vertical migration cells.
2.8. Statistical Analysis. Data are presented as mean ± SEM.
Comparisons were made by one-way ANOVA followed by
Student-Newman-Keuls post hoc analysis. Data were analyz-
ed with Microsoft Excel 2003 (Microsoft Inc., Seattle, WA,
USA) and SPSS 12.0 for Windows (SPSS Inc., Chicago, IL,
USA). Statistical analyses were performed using the aver-
age results of three repeated experiments under identical
conditions. A P value <0.05 was considered statistically sig-
niﬁcant. Diﬀerences were considered signiﬁcant if P<0.05.
3. Results
3.1. Establishment of the Fibroblast Cell Model of High MMP9
Expression. High glucose and high homocysteine induced
MMP9 expression obviously. mRNA and protein expression
and protease activity of MMP9 in model group were 6.05-,
4.12-, and 1.62-fold, respectively, higher than those in con-
trol group (P<0.01). This suggested that the ﬁbroblasts
cellmodelofhighMMP9expressionwascreatedsuccessfully.
When the cells were treated with TIMP1 (100μg/L), MMP9
protease activity decreased by 70.7% signiﬁcantly (P<
0.01), while MMP9 mRNA and protein expression had no
statistical diﬀerences compared with those in model group
(P>0.05) (Figures 1 and 2).
3.2. Inhibition of Fibroblasts Proliferation, Viability, and Col-
lagen Secretion by High MMP9 Expression. Compared with
thoseincontrolgroup,ﬁbroblastsproliferation,viability,and
collagen secretion in model group were inhibited with 29.8%
of S-phase cell ratio, 18.1% of proliferation index, 23.3%
of cell viability, and 68.7% of collagen secretion (P<0.01,4 Experimental Diabetes Research
Table 1: Proliferation, viability, and collagen secretion of ﬁbroblasts.
Group S-phase cell ratio (%) Proliferation index (%) CCK-8 OD value Hydroxyproline (pg/mL)
Control group 9.31 ±0.24 13.8 ±0.51 .76 ±0.13 1126.4 ±62.7
Model group 6.54 ±0.29∗ 11.3 ±0.6∗ 1.35 ±0.12∗ 352.8 ±60.6∗
TIMP1 group 7.75 ±0.27∗# 12.5 ±0.5∗§ 1.64 ±0.14# 828.6 ±58.9∗#
TIMP1: tissue inhibitor of metalloproteinase 1; ∗P<0.01 versus control group; §P<0.05; #P<0.01 versus model group. Data are mean ± SEM, n = 5.
resp.). After treatment with TIMP1, the inhibition reduced
compared with those in model group (P<0.05) (Table 1).
3.3. Inhibition of Fibroblasts Horizontal Migration by High
MMP9 Expression. The horizontal migration rate of ﬁbrob-
lasts in model group (21.3 ± 2.1)% was lower than that in
control group (38.7 ± 2.6)% with the inhibition rate being
45.0% (P<0.01). After treatment with TIMP1, the horizon-
talmigrationrate(31.5±2.7)%increasedcomparedwiththat
in model group but failed to recover to the level of control
group (P<0.01, resp.) (Figure 3).
3.4. Inhibition of Fibroblasts Vertical Migration by High
MMP9 Expression. Compared with control group (90.6 ±
3.8), the vertical migration of cells decreased by 21.4% in
model group (71.2 ± 3.8) (P<0.01). After treatment with
TIMP1, the vertical migration of cells (85.3 ± 3.7) increased
compared with that in model group but failed to recover to
the level of control group (P<0.01) (Figure 4).
4. Discussion
Fibroblasts are major repair cells in the skin, which account
for 40% to 60% of total cells. The biological eﬀects of
ﬁbroblasts play vital roles in wound healing [19]. Scholars
have found that the DNA synthesis of skin ﬁbroblasts signi-
ﬁcantlydecreased,whileapoptosisincreased,inpatientswith
diabetes, which indicates that the proliferation of ﬁbroblasts
was inhibited in the pathological statement of diabetes [20].
Studies in rats demonstrated similar results to those in
humans [21]. However, whether the changes in biological
behaviors of ﬁbroblasts are related to high MMP9 expression
in the diabetes is still unknown.
To avoid the complicating factors in vivo, high concen-
trationsofglucoseandhomocysteinewereusedtomimicthe
local environment of diabetic skin [12]. Results of this study
showedthatMMP9expressionsofﬁbroblastsincreasedwhen
cultured in high glucose and high homocysteine medium.
The expressions of MMP9 mRNA, protein levels, and pro-
teaseactivityinhigh-glucoseandhigh-homocysteine-treated
group were 6.05-, 4.12-, and 1.62-fold, respectively, higher
than those in control group, which suggested that high
expression of MMP9 was induced.
At the same time, the S-phase cell ratio, proliferation
index and cell viability in high-glucose and high-homocy-
steine-treated group decreased signiﬁcantly compared with
thoseincontrolgroup.AftertreatmentbyTIMP1,expression
ofMMP9mRNAandproteinlevelshadnostatisticalchange,
but activity of MMP9 protein was inhibited signiﬁcantly,
together with the increase of S-phase cell ratio, proliferation
index, and cell viability. These results suggested that the in-
hibition of ﬁbroblasts proliferation and viability were likely
related with the high activity of MMP9.
Wound healing depends on the ﬁbroblasts proliferation,
migration, granulation tissue formation, collagen secretion,
and collagen-based scar formation, which need the partic-
ipation of many diﬀerent cells [22]. As ﬁbroblasts are the
most important cells of collagen synthesis [23], barriers of
proliferation and vitality inevitably have negative eﬀects on
newcollagensynthesisandwoundhealing.Thepresentstudy
foundthat,comparedwiththatincontrolgroup,theamount
of hydroxyproline in model group decreased by 68.7%. After
treatmentbyTIMP1,thehydroxyprolinesynthesisincreased.
The result suggested that in the diabetic status, not only did
high protease activity of MMP9 increase the degradation
of extracellular matrix [24] but also the collagen synthesis
was decreased because of the decrease in the number and
activityofﬁbroblasts.Thusthecollagenmetabolismwaskept
in negative balances and will ultimately delay the healing of
diabetic wounds.
Migration is another biological property of ﬁbroblasts
[25]. It is generally accepted that there is a positive corre-
lation between expression of MMP9 and migration behavior
of cells [26, 27]. In our study, it is very interesting that both
the horizontal and vertical migration abilities of ﬁbroblasts
were signiﬁcantly decreased in model group. The possible
mechanisms of this phenomenon may be as follows. Firstly,
highexpressionofMMP9mayresultinexcessivematrixpro-
teindegradation,whichisnecessarytosupportthemigration
of ﬁbroblasts. Our previous data showed that the expression
level of MMP9 of the skin was signiﬁcantly enhanced during
wound healing in diabetic rats [4–6]. Reiss et al. [28]f u r -
ther demonstrated that exogenous MMP9 directly delayed
wound healing in a mouse model. Secondly, increased activi-
ty of MMP9 is capable of cleaving nonmatrix proteins [29],
which are essential to the migration of cells [30]. Kyriakides
et al. [31] found that antibody-based blockade of MMP9
function or MMP9 deﬁciency retarded migration, and the
rate of reepithelialization was signiﬁcantly delayed in MMP9
knockout mice when compared with wide-type mice. In this
study, the migration ability of ﬁbroblasts in model group
decreased, which will prevent ﬁbroblasts from crawling to
the site of wound in time to play their roles. Because the
inhibition of ﬁbroblasts proliferation, viability, and colla-
gen synthesis, even if they migrate to the site of wound,
they still cannot function normally—they cannot proliferate
eﬃciently to make up adequate cells and they can not pro-
duce enough extracellular matrix and cell factors, so that the
normal cycle of wound healing is broken, and this will cause
the disorder of wound healing.Experimental Diabetes Research 5
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Figure 3: Scratch test of each group. (a) Control group 0h (×40); (b) model group 0h (×40); (c) tissue inhibitor of metalloproteinase
1 (TIMP1) group 0h (×40); (d) control group 6h (×40); (e) model group 6h (×40); (f) TIMP1 group 6h (×40); (g) histogram. The
horizontal migration rate of ﬁbroblasts in model group was lower than that in control group with the inhibition rate being 45.0%. After
treatment with TIMP1, the horizontal migration rate increased compared with that in model group, but failed to recover to the level of
control group. ∗P<0.01 versus control group; #P<0.01 versus model group. Data are mean ± SEM, n = 5.
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Figure 4: Vertical migration of ﬁbroblasts. (a) Control group (×100); (b) model group (×100); (c) tissue inhibitor of metalloproteinase 1
(TIMP1) group (×100). Compared with control group, the vertical migration of cells decreased by 21.4% in model group. After treatment
with TIMP1, the vertical migration of cells increased compared with that in model group but failed to recover to the level of control group.6 Experimental Diabetes Research
5. Conclusion
Inourpreviousstudies,ﬁbroblastsexhibitedanupregulation
of MMP9 as a result of high glucose and high homocysteine
incubation [10, 11]. The present study further proved that
the biological behaviors of rat dermal ﬁbroblasts can be
inhibited by high level of MMP9, and the inhibited eﬀect
can be reduced by TIMP1, which can inhibit the activity of
MMP9. So we believe that inhibiting the activity of MMP9
maybeafeasiblewaytoacceleratethehealingofdiabetesskin
ulcers. However, the delayed wound healing is a complicated
procedure, and the potential involvement of other MMP
and TIMP family members and related cytokines still needs
further investigation.
Deﬁciencies:Thepresentstudyisperformedinvitro,and
the results of this research remain to be further conﬁrmed in
future animal experiments.
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